logo

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

Aventis Pharmaceuticals Inc.


USPTO Granted Patents = 207



Trademarks = 8

Forward Citations = 1,930

Loading Chart...
Loading Chart...

429 inventors (with patents filed for the assignee):

goldMedal Yulin Chiang (16 out of 98 patents)

silverMedal Kenneth J Bordeau (13 out of 54 patents)

bronzeMedal Joseph T Strupczewski (11 out of 83 patents)

4.  Michael R Myers (11 out of 37 patents)

5.  Alfred P Spada (11 out of 52 patents)

6.  John G Jurcak (11 out of 33 patents)

7.  David Fink (9 out of 10 patents)

8.  Martin P Maguire (9 out of 24 patents)

9.  Edward J Glamkowski (8 out of 116 patents)

10.  Norton P Peet (8 out of 87 patents)

11.  Raymond W Kosley, Jr (8 out of 66 patents)

12.  Yong Mi Choi-Sledeski (7 out of 16 patents)

13.  Gregory Bernard Poli (7 out of 13 patents)

14.  Timothy A Gillespy (7 out of 8 patents)

15.  Sukanthini Thurairatnam (7 out of 10 patents)


Core Competencies:
Phosphinic Acid Derivatives
Cardiovascular Morbidity
Nuclear Factor Kappa B
Poly(ADP-Ribose) Polymerase Inhibitors
Dopamine Agonists
Retroviral Vectors
Prostaglandin Receptor Antagonists
Heterocyclic Compounds
Nucleic Acid Molecules
Dihydrogen Phosphate Salts
Demyelinating Diseases
Kinase Inhibitors

207 patents:

1. 8828974 - Substituted propane phosphinic acid derivatives (2014-09-09),
2. 8809270 - Method for reducing cardiovascular morbidity and mortality in prediaetic patients and patients with type 2 diabetes (2014-08-19),
3. 8642739 - Nuclear factor κB inducing factor (2014-02-04),
4. 8623831 - Nuclear factor κB inducing factor (2014-01-07),
5. 8343494 - Antibodies against LLG polypeptides of the triacylglycerol lipase family (2013-01-01),
6. 8288425 - Benzimidazoles (2012-10-16),
7. 8202863 - Pyrimidine amide compounds as PGDS inhibitors (2012-06-19),
8. 8193183 - 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists (2012-06-05),
9. 8183231 - Substituted propane phosphinic acid derivatives (2012-05-22),
10. 8173682 - Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) (2012-05-08),
11. 8053458 - Dipyrazole compounds and their use as central nervous system agents (2011-11-08),
12. 8008491 - Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP) (2011-08-30),
13. 8008340 - 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase I (2011-08-30),
14. 7989584 - AKT nucleic acids, polypeptides, and uses thereof (2011-08-02),
15. 7977310 - Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes (2011-07-12),
Aventis Pharmaceuticals Inc. is a leading pharmaceutical company dedicated to improving global health. With a strong focus on research and development, we innovate and deliver high-quality medicines that address a wide range of medical conditions. Our committed team of experts strive to enhance patient outcomes through a customer-centric approach and advanced technologies. Visit our website to learn more about our products, collaborations, and our dedication to improving the well-being of individuals worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

207 Patents

#4 in Bridgewater, NJ

#93 in New Jersey

#1,934 in US

#3,992 in the World

...
Bridgewater, NJ, United States of America

Aventis Pharmaceuticals Inc.

Forward Citations = 1,930

429 inventors:

goldMedal Yulin Chiang (16 out of 98 patents)

silverMedal Kenneth J Bordeau (13 out of 54 patents)

bronzeMedal Joseph T Strupczewski (11 out of 83 patents)

4.  Michael R Myers (11 out of 37 patents)

5.  Alfred P Spada (11 out of 52 patents)

Please report any incorrect information to support@idiyas.com
Loading…